Obesity paradox seen in T2DM modified by smoking status

July 9, 2018

(HealthDay)—Smoking status heavily modifies the obesity paradox observed in people with type 2 diabetes, according to a study published online July 3 in Diabetes Care.

David A. Jenkins, from the University of Manchester in the United Kingdom, and colleagues studied 502,631 participants in the general U.K. Biobank population as well as three subgroups of people with type 2 diabetes (23,842 participants), coronary heart disease (CHD; 24,268 participants), and cancer (45,790 participants). Adiposity exposures, including (BMI), , , and waist-to-hip ratio, were considered.

The researchers found that the obesity paradox was observed for BMI among people with type 2 diabetes but not those with CHD (adjusted hazard ratio for obese versus normal BMI, 0.78 [95 percent confidence interval, 0.65 to 0.95] and 1.00 [95 percent confidence interval, 0.86 to 1.17] for type 2 diabetes and CHD, respectively). Current smokers had a more pronounced obesity paradox, while it was absent in never smokers; the paradox was more pronounced in men than women. There was less evidence for an obesity paradox for other adiposity measures; smoking consistently modified the relationship between adiposity and mortality.

"The obesity paradox was observed in people with type 2 diabetes and is heavily modified by smoking status," the authors write. "The results of subgroup analyses and statistical adjustments are consistent with reverse causality and confounding."

Explore further: Study of nearly 300,000 people challenges the 'obesity paradox'

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Study of nearly 300,000 people challenges the 'obesity paradox'

March 15, 2018
The idea that it might be possible to be overweight or obese but not at increased risk of heart disease, otherwise known as the "obesity paradox", has been challenged by a study of nearly 300,000 people published in in the ...

Smoking linked with higher risk of type 2 diabetes

March 15, 2018
The prevalence of diabetes has increased almost 10-fold in China since the early 1980s, with one in 10 adults in China now affected by diabetes. Although adiposity is the major modifiable risk factor for diabetes, other research ...

Type 2 diabetes ups risk of renal cancer in women, but not men

May 8, 2018
(HealthDay)—Type 2 diabetes is independently associated with a greater risk of renal cell carcinoma (RCC) in women, but not in men, according to a study published online April 20 in Diabetes Care.

The obesity paradox: People hospitalized for infections are twice as likely to survive if they are overweight or obese

May 25, 2018
A study of more than 18,000 patients in Denmark, presented at this year's European Congress on Obesity in Vienna, Austria (23-26), shows that patients admitted to hospital for treatment for any infectious disease are around ...

Wide waist with 'normal weight' bigger risk than obesity: study

April 20, 2018
People of "normal" weight who sport a wide waist are more at risk of heart problems than obese people, said researchers Friday, urging a rethink of healthy weight guidelines.

Adiposity genetic risk score tied to cardiometabolic health

May 4, 2016
(HealthDay)—Data from a large cohort have replicated the association between the genetic risk score of 11 favorable adiposity variants with lower risk of cardiometabolic disease, according to research published online April ...

Recommended for you

Switching to certain antidiabetic drugs linked to increased risk of major complications

July 18, 2018
For people with type 2 diabetes, switching to sulfonylurea drugs to control blood sugar levels is associated with an increased risk of complications compared with staying on the drug metformin, finds a study in The BMJ today.

Researchers cure type 2 diabetes and obesity in mice using gene therapy

July 10, 2018
A research team from the UAB led by Professor Fatima Bosch has managed to cure obesity and type 2 diabetes in mice using gene therapy.

Human clinical trial reveals verapamil as an effective type 1 diabetes therapy

July 9, 2018
Researchers at the University of Alabama at Birmingham Comprehensive Diabetes Center have discovered a safe and effective novel therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent ...

New targets found to reduce blood vessel damage in diabetes

July 9, 2018
In diabetes, both the tightly woven endothelial cells that line our blood vessels and the powerhouses that drive those cells start to come apart as early steps in the destruction of our vasculature.

Insurance gaps linked to five-fold rise in hospital stays for adults with type 1 diabetes

July 9, 2018
For a million American adults, living with type 1 diabetes means a constant need for insulin medication, blood sugar testing supplies and specialized care, to keep them healthy and prevent a crisis that could end up in an ...

Abnormal branched-chain amino acid breakdown may raise diabetes risk

July 5, 2018
In the U.S., about five out of 100 expectant mothers develop gestational diabetes mellitus (GDM), a temporary form of diabetes in which hormonal changes disrupt insulin function. Although GDM is often symptomless and subsides ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.